Tango Therapeutics Q3'26 Results Scheduled for November 10
Tango Therapeutics is scheduled to report Q3'26 results on November 10; the report is expected at 7:00 a.m. ET. EPS is anticipated at $(0.35).
TNGX (Tango Therapeutics, Inc.) is set to announce its Q3'26 results on November 10, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.35) USD. Learn more details at TNGX Fi…